Compare Revvity Inc (RVTY) vs Schwab US Dividend Equity ETF (SCHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Schwab US Dividend Equity ETF — how do they compare? Revvity Inc trades at $117.95 (market cap $12.91B), while Schwab US Dividend Equity ETF trades at $34.3. The key difference: Revvity Inc pays a 0.24% dividend while Schwab US Dividend Equity ETF pays none. Which is the better fit depends on your goals.
| RVTY | SCHD | |
|---|---|---|
Market Cap | $12.91B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $117.88 | $34.27 |
52-Week Low | $82.26 | $26.44 |
Enterprise Value | $15.23B | — |
Dividend Yield | 0.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
SCHD trades at $34.26, showing modest daily gains of 0.2% with strong bullish technical signals from moving averages. The ETF maintains its position as a core dividend equity holding, though key valuation metrics remain unavailable in current data. Recent institutional activity shows Barry Investment Advisors increased their position by 29.9% during Q2 2026, indicating continued institutional confidence in the fund's strategy.
SCHD faces competition from alternative income ETFs while benefiting from the current market rotation toward value strategies. The fund's 2% yield and dividend-focused approach appeal to retirement investors, though tax efficiency considerations remain crucial for optimal positioning. Market sentiment suggests SCHD serves as a defensive holding in volatile environments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Schwab US Dividend Equity ETF
SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →
